Publications by authors named "David I Rodenhiser"

Claim this Profile
E
Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders.
Erfan Aref-Eshghi, Jennifer Kerkhof, Victor P Pedro, Groupe DI France, Mouna Barat-Houari, David I Rodenhiser

Am J Hum Genet· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders.
Erfan Aref-Eshghi, Jennifer Kerkhof, Victor P Pedro, , Mouna Barat-Houari, David I Rodenhiser

Am J Hum Genet· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Utility of Genome-wide DNA Methylation Testing in Genetically Unsolved Individuals with Suspected Hereditary Conditions.
Erfan Aref-Eshghi, Eric G Bend, Samantha Colaiacovo, Michelle Caudle, Rana Chakrabarti, David I Rodenhiser

Am J Hum Genet· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood epi-signature of Claes-Jensen syndrome enables sensitive and specific identification of patients and healthy carriers with pathogenic mutations in .
Laila C Schenkel, Erfan Aref-Eshghi, Cindy Skinner, Peter Ainsworth, Hanxin Lin, David I Rodenhiser

Clin Epigenetics· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAFopathies' DNA methylation epi-signatures demonstrate diagnostic utility and functional continuum of Coffin-Siris and Nicolaides-Baraitser syndromes.
Erfan Aref-Eshghi, Eric G Bend, Rebecca L Hood, Laila C Schenkel, Deanna Alexis Carere, David I Rodenhiser

Nat Commun· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic DNA Methylation-Derived Algorithm Enables Accurate Detection of Malignant Prostate Tissues.
Erfan Aref-Eshghi, Laila C Schenkel, Peter Ainsworth, Hanxin Lin, David I Rodenhiser

Front Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of epigenetic signature associated with alpha thalassemia/mental retardation X-linked syndrome.
Laila C Schenkel, Kristin D Kernohan, Arran McBride, Ditta Reina, Amanda Hodge, David I Rodenhiser

Epigenetics Chromatin· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes.
Erfan Aref-Eshghi, David I Rodenhiser, Laila C Schenkel, Hanxin Lin, Cindy Skinner

Am J Hum Genet· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation analysis in constitutional disorders: Clinical implications of the epigenome.
Laila C Schenkel, David I Rodenhiser, Peter J Ainsworth, Guillaume Paré, Bekim Sadikovic

Crit Rev Clin Lab Sci· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array.
Laila C Schenkel, Charles Schwartz, Cindy Skinner, David I Rodenhiser, Peter J Ainsworth

J Mol Diagn· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide analysis in human colorectal cancer cells reveals ischemia-mediated expression of motility genes via DNA hypomethylation.
Karolina Skowronski, Joseph Andrews, David I Rodenhiser, Brenda L Coomber

PLoS One· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetics, eh! A meeting summary of the Canadian Conference on Epigenetics.
David I Rodenhiser, Nathalie G Bérubé, Mellissa R W Mann

Epigenetics· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene signatures of breast cancer progression and metastasis.
David I Rodenhiser, Joseph D Andrews, Theodore A Vandenberg, Ann F Chambers

Breast Cancer Res· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human 21T breast epithelial cell lines mimic breast cancer progression in vivo and in vitro and show stage-specific gene expression patterns.
Lesley H Souter, Joseph D Andrews, Guihua Zhang, Amy C Cook, Carl O Postenka, David I Rodenhiser

Lab Invest· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number.
Joseph Andrews, Wendy Kennette, Jenna Pilon, Alexandra Hodgson, Alan B Tuck, David I Rodenhiser

PLoS One· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment.
Terlika S Pandit, Wendy Kennette, Lisa Mackenzie, Guihua Zhang, Waleed Al-Katib, David I Rodenhiser

Int J Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
David I Rodenhiser, Joseph Andrews, Wendy Kennette, Bekim Sadikovic, Ariel Mendlowitz

Breast Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic contributions to cancer metastasis.
David I Rodenhiser

Clin Exp Metastasis· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
Paul Goss, Alison L Allan, David I Rodenhiser, Paula J Foster, Ann F Chambers

APMIS· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct karyotypes in three breast cancer cell lines --21PTCi, 21NTCi, and 21MT-1 --derived from the same patient and representing different stages of tumor progression.
Jie Xu, Lesley H Souter, Ann F Chambers, David I Rodenhiser, Alan B Tuck

Cancer Genet Cytogenet· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells.
Bekim Sadikovic, Joseph Andrews, David Carter, John Robinson, David I Rodenhiser

J Biol Chem· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular cytogenetic characterization of human breast cancer cell line MDA-MB-468 and its variant 468LN, which displays aggressive lymphatic metastasis.
Jie Xu, Ann F Chambers, Alan B Tuck, David I Rodenhiser

Cancer Genet Cytogenet· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Bekim Sadikovic, Joseph Andrews, David I Rodenhiser

Toxicol Appl Pharmacol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.
Darci T Butcher, David I Rodenhiser

Eur J Cancer· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells.
Bekim Sadikovic, David I Rodenhiser

Toxicol Appl Pharmacol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis